Lonafarnib for treating progeria and progeroid laminopathies [ID3867]

Status:

Topic prioritisation

Technology type:

Medicine

Decision:

Not selected

Rationale:

This topic was presented to the Topic Selection Oversight Panel (TSOP) in April 2021. The panel agreed that there was no clear rationale for an evaluation, and it would not add value to the NHS. The topic was not selected for the TA-HST work programme.

ID number:

3867

Timeline

Key events during the development of the guidance:

For further information on how we select topics for development, please see our page about topic prioritisation